MTOR and cancer: Furthermore, treatment of cancer cells harboring wt p53 with Ribavirin induced mammalian target of rapamycin (mTOR)-dependent activation of p53 that resulted in IRF9 transcriptional upregulation and enhancement of IFN signaling [48].